XM does not provide services to residents of the United States of America.
I
I

Infosys

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Infosys Collaborates With Clearstream

BRIEF-Infosys Collaborates With Clearstream Sept 11 (Reuters) - Infosys Ltd INFY.NS : COLLABORATES WITH CLEARSTREAM Source text for Eikon: ID:nBSE1YDLwj Further company coverage: INFY.NS
I

Infosys, Proximus Group Strengthen Strategic Collaboration

BRIEF-Infosys, Proximus Group Strengthen Strategic Collaboration Sept 10 (Reuters) - Infosys Ltd INFY.NS : INFOSYS - INFOSYS AND PROXIMUS GROUP STRENGTHEN THEIR STRATEGIC COLLABORATION Further company coverage: INFY.NS
I

Indian IT rally not over yet, says Morgan Stanley

BUZZ-Indian IT rally not over yet, says Morgan Stanley ** India's IT stocks have jumped 12%-40% since early June (vs Sensex's 12% gain) and the rally is not yet over, says Morgan Stanley ** MS says Q1 marks beginning of rev upgrade cycle and sees growth to continue for at least 1-2 quarters on likelihood of US rate cuts this month, pickup in BFSI s
I

Gen AI boosting productivity of Indian IT industry's fastest-growing niche, TCS exec says

Gen AI boosting productivity of Indian IT industry's fastest-growing niche, TCS exec says By Sai Ishwarbharath B BENGALURU, Sept 5 (Reuters) - Generative AI is helping India's top IT firm Tata Consultancy Services TCS.NS accelerate development in the industry's fastest-growing niche of engineering research and design, a senior executive told Reuters.
C
I
S
R

Indian shares moderate post global sell-off

BUZZ-Indian shares moderate post global sell-off ** India's Nifty 50 .NSEI and Sensex .BSESN largely flat as traders look for fresh cues to get clarity on the U.S. economy ** Ten of the 13 major sectoral indexes log marginal gains ** Weak economic data from the U.S. indicate a potential slowdown in the U.S. economy, weighing on for global markets including domestic equities, analysts said ** Asian shares were subdued in a data-packed week, investors are scouring for clues to the health of the U.
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.